Duchenne Muscular Dystrophy Research Consortium
GPTKB entity
Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Association
|
| gptkbp:advocatesFor |
policy changes
patient rights research funding |
| gptkbp:aimsTo |
improve quality of life
improve patient outcomes enhance collaboration reduce disease burden accelerate drug development advance research improve research outcomes enhance patient access foster research innovation |
| gptkbp:analyzes |
clinical data
|
| gptkbp:collaboratesWith |
international organizations
research institutions |
| gptkbp:conducts |
educational programs
workshops |
| gptkbp:coordinates |
research projects
multicenter studies patient support programs |
| gptkbp:develops |
clinical guidelines
strategic partnerships research priorities therapeutic strategies |
| gptkbp:encourages |
patient participation
cross-disciplinary research |
| gptkbp:engagesIn |
public engagement
community outreach patient advocacy policy advocacy fundraising activities |
| gptkbp:established |
collaborative networks
|
| gptkbp:facilitates |
knowledge sharing
data sharing networking opportunities information exchange clinical collaborations |
| gptkbp:focusesOn |
gptkb:Duchenne_Muscular_Dystrophy
|
| gptkbp:fosters |
scientific collaboration
innovation in treatment |
| gptkbp:hosts |
annual meetings
|
| https://www.w3.org/2000/01/rdf-schema#label |
Duchenne Muscular Dystrophy Research Consortium
|
| gptkbp:involves |
families of patients
|
| gptkbp:market |
best practices
|
| gptkbp:promotes |
research collaboration
scientific exchange research transparency awareness_of_Duchenne_Muscular_Dystrophy |
| gptkbp:provides |
resources for researchers
training for researchers clinical resources clinical trial information expertise_in_DMD |
| gptkbp:publishes |
research findings
|
| gptkbp:receives |
funding from grants
|
| gptkbp:supports |
educational resources
clinical trials patient registries research initiatives biomedical research longitudinal studies patient care initiatives |
| gptkbp:utilizes |
biomarkers
|
| gptkbp:worksWith |
government agencies
pharmaceutical companies clinical researchers healthcare_providers |